Kelly Shi
Stock Analyst at Jefferies
(2.45)
# 2,502
Out of 5,006 analysts
32
Total ratings
43.33%
Success rate
3.96%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $129 → $148 | $158.28 | -6.49% | 2 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $15.90 | +76.10% | 1 | Jul 7, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $22.15 | +98.65% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $8.61 | +74.22% | 1 | Apr 10, 2025 | |
| OPT Opthea | Downgrades: Underperform | $1 | $3.41 | -70.67% | 1 | Mar 25, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $18.43 | +182.15% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $4.53 | +209.05% | 2 | Dec 16, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $13 → $19 | $23.00 | -17.39% | 2 | Sep 11, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $174 → $196 | $210.83 | -7.03% | 2 | Aug 13, 2024 | |
| ARTV Artiva Biotherapeutics | Initiates: Buy | $21 | $2.93 | +616.72% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $16.40 | +125.61% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $2.90 | +106.90% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $46 | $64.80 | -29.01% | 3 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $87.23 | -7.14% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $19.89 | +75.97% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.44 | +1,375.41% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $8.66 | +84.76% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $57.55 | -30.50% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $7.66 | +161.10% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.53 | +216.21% | 1 | Aug 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $1.00 | +2,600.00% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $16.22 | +220.59% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $1.60 | +1,587.50% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $1.99 | +1,558.29% | 1 | Mar 8, 2021 |
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129 → $148
Current: $158.28
Upside: -6.49%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $15.90
Upside: +76.10%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $22.15
Upside: +98.65%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $8.61
Upside: +74.22%
Opthea
Mar 25, 2025
Downgrades: Underperform
Price Target: $1
Current: $3.41
Upside: -70.67%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $18.43
Upside: +182.15%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $4.53
Upside: +209.05%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $23.00
Upside: -17.39%
Ascendis Pharma
Aug 13, 2024
Maintains: Buy
Price Target: $174 → $196
Current: $210.83
Upside: -7.03%
Artiva Biotherapeutics
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $2.93
Upside: +616.72%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $16.40
Upside: +125.61%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $2.90
Upside: +106.90%
May 20, 2024
Maintains: Buy
Price Target: $35 → $46
Current: $64.80
Upside: -29.01%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $87.23
Upside: -7.14%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $19.89
Upside: +75.97%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $2.44
Upside: +1,375.41%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $8.66
Upside: +84.76%
Aug 15, 2022
Initiates: Buy
Price Target: $40
Current: $57.55
Upside: -30.50%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $7.66
Upside: +161.10%
Aug 3, 2022
Initiates: Buy
Price Target: $8
Current: $2.53
Upside: +216.21%
Mar 4, 2022
Initiates: Buy
Price Target: $27
Current: $1.00
Upside: +2,600.00%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $16.22
Upside: +220.59%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $1.60
Upside: +1,587.50%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $1.99
Upside: +1,558.29%